Post-mortem from Canaccord HCV conference: I recommend the afternoon panel discussion, which included the head of marketing at VRUS and the CMO at VRTX. On the other hand, the lunchtime panel from HCV clinicians was a waste of time, IMO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.